(Q41766698)

English

Clinical response to eliglustat in treatment-naïve patients with Gaucher disease type 1: Post-hoc comparison to imiglucerase-treated patients enrolled in the International Collaborative Gaucher Group Gaucher Registry

scientific article published on 27 June 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Clinical response to eliglustat in treatment-naïve patients with Gaucher disease type 1: Post-hoc comparison to imiglucerase-treated patients enrolled in the International Collaborative Gaucher Group Gaucher Registry (English)

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

1 reference

based on heuristic

inferred from title

Gaucher's disease

1 reference

based on heuristic

inferred from title

author name string

Jennifer Ibrahim

1

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Lisa H Underhill

2

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

John S Taylor

3

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Jennifer Angell

4

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

M Judith Peterschmitt

5

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

language of work or name

0 references

publication date

27 June 2016

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Molecular Genetics and Metabolism Reports

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

8

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

17-19

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

6 June 2018

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

6 June 2018

Revised recommendations for the management of Gaucher disease in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

6 June 2018

ELIGLUSTAT TARTRATE: Glucosylceramide Synthase Inhibitor Treatment of Type 1 Gaucher Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

6 June 2018

A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

6 June 2018

Phenotype, diagnosis, and treatment of Gaucher's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

6 June 2018

Gaucher disease: review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

6 June 2018

Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4927653

18 August 2018

Eliglustat tartrate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGMR.2016.06.003

7 January 2021

Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGMR.2016.06.003

7 January 2021

Identifiers

10.1016/J.YMGMR.2016.06.003

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41766698&oldid=2110347564"